| GTO ID | GTC2138 |
| Trial ID | NCT04008524 |
| Disease | Refractory Hematologic Cancer |
| Therapy | CAR-T cell |
| Treatment | HY001502 |
| Recruitment status | Available |
| Title | A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies |
| Year | 2019 |
| Country | China |
| Company sponsor | Institute of Hematology & Blood Diseases Hospital |
| Other ID(s) | HY001502 |
| Cohort 1 | |||||||
|
|||||||